Targeted Diagnostics for Global Health Frontiers.
In endemic regions, a fever demands rapid and accurate differentiation. Our field-ready diagnostic tools are designed for certainty in the most challenging environments—a reliability engineered at the source by our `NomoFlow™` platform.
Our Field-Ready Diagnostics Portfolio
Comprehensive solutions for the diagnosis of febrile illnesses in endemic regions.
Dengue IgG/IgM / NS1 Antigen Combo Rapid Test
Provides full-spectrum disease state insight by distinguishing between acute and past Dengue infections.
Malaria Pf/Pan Antigen Rapid Test
Rapidly diagnoses malaria and differentiates the most fatal species, P. falciparum.
Malaria Pf/Pv Antigen Rapid Test
Differentiates between the two most common malaria parasites, P. falciparum and P. vivax.
Zika Virus IgG/IgM Antibody Rapid Test
For the mosquito-borne disease that poses a significant risk to pregnant women.
Chikungunya IgM/IgG Antibody Rapid Test
For the disease characterized by severe, debilitating joint pain.
Lyme (Borrelia burgdorferi) Antibody Rapid Test
Differential diagnosis for the common tick-borne disease in temperate climates.
Case Study in Precision: The Dengue Combo Test
A single test that accurately detects one antigen (NS1 for early infection) and two antibody classes (IgM/IgG) requires manufacturing at the highest level of precision.
The NomoFlow™ platform ensures that three distinct reagent lines are deposited perfectly, without variance, on millions of tests. This eliminates the risk of false positives from cross-reactivity and guarantees that each component of this complex diagnostic tool performs reliably, providing clinicians a complete picture of the patient's infection status.
